A clinicopathological study of lung adenocarcinomas with pure ground-glass opacity > 3 cm on high-resolution computed tomography
- 16 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 32 (1), 174-183
- https://doi.org/10.1007/s00330-021-08115-1
Abstract
Objectives This study aimed to discuss whether a diameter of 3 cm is a threshold for diagnosing lung adenocarcinomas presenting with radiological pure ground-glass mass (PGGM, pure ground-glass opacity > 3 cm) as adenocarcinomas in situ or minimally invasive adenocarcinomas (AIS-MIAs). Another aim was to identify CT features and patient prognosis that differentiate AIS-MIAs from invasive adenocarcinomas (IACs) in patients with PGGMs. Methods From June 2007 to October 2015, 69 resected PGGMs with HRCT and followed up for ≥ 5 years were included in this study and divided into AIS-MIA (n = 13) and IAC (n = 56) groups. Firth’s logistic regression model was performed to determine CT characteristics that helped distinguish IACs from AIS-MIAs. The discriminatory power of the significant predictors was tested with the area under the receiver operating characteristics curve (AUC). Disease recurrence was also evaluated. Results Univariable and multivariable analyses identified that the mean CT attenuation (odds ratio: 1.054, p = 0.0087) was the sole significant predictor for preoperatively discriminating IACs from AIS-MIAs in patients with PGGMs. The CT attenuation had an excellent differentiating accuracy (AUC: 0.981), with the optimal cut-off value at −600 HU (sensitivity: 87.5%; specificity: 100%). Additionally, no recurrence was observed in patients manifesting with PGGMs > 3 cm, and the 5-year recurrence-free survival and overall survival rates were both 100%, even in cases of IAC. Conclusions This study demonstrated that PGGMs > 3 cm could still be AIS-MIAs. When PGGMs are encountered in clinical practice, the CT value may be the only valuable parameter to preoperatively distinguish IACs from AIS-MIAs. Key Points • Patients with pure ground-glass opacity > 3 cm in diameter are rare but can be diagnosed as adenocarcinomas in situ or minimally invasive adenocarcinomas. • The mean CT attenuation is the sole significant CT parameter that differentiates invasive adenocarcinoma from adenocarcinoma in situ or minimally invasive adenocarcinoma in patients with pure ground-glass opacity > 3 cm. • Lung adenocarcinoma with pure ground-glass opacity > 3 cm has an excellent prognosis, even in cases of invasive adenocarcinoma.This publication has 27 references indexed in Scilit:
- Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameterLung Cancer, 2019
- CT diagnosis of pleural and stromal invasion in malignant subpleural pure ground-glass nodules: an exploratory studyEuropean Radiology, 2018
- Tumor invasiveness defined by IASLC/ATS/ERS classification of ground-glass nodules can be predicted by quantitative CT parametersJournal of Thoracic Disease, 2017
- The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology, 2016
- CT characteristics and pathological implications of early stage (T1N0M0) lung adenocarcinoma with pure ground-glass opacityEuropean Radiology, 2015
- Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and ManagementAmerican Journal of Roentgenology, 2014
- Persistent Pure Ground-Glass Opacity Lung Nodules ≥ 10 mm in Diameter at CT ScanSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Recommendations for the Management of Subsolid Pulmonary Nodules Detected at CT: A Statement from the Fleischner SocietyRadiology, 2013
- Natural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low-Dose CT ScanSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaJournal of Thoracic Oncology, 2011